how long will semaglutide be on the shortage list ends as FDA sets deadline for compounders Despite FDA ruling, compounded GLP-1s

Cramping is a side effect of GLP-1 activation in muscle tissue and rapid metabolic changes, not a sign of treatment failure

J., Beck, R

Not just what each therapy does, but when it makes sense to choose one over the other, and when combining them is the smarter move

These side effects are not permanentthey follow a predictable pattern that typically resolves within 48 weeks as your body adjusts to the medication

Among participants without diabetes, cardiovascular risk reduction was consistent across all baseline HbA1c subgroups (less than 5.7%, 5.7% to 6.0%, and 6.0% to 6.5%) and across categories of HbA1c change from baseline to 20 weeks